DaVita Inc. $DVA Stock Acquired by ProShare Advisors LLC

ProShare Advisors LLC boosted its holdings in DaVita Inc. (NYSE:DVA) by 99.3% in the third quarter, HoldingsChannel reports. The firm owned 13,161 shares of the company’s stock after purchasing an additional 6,558 shares during the period. ProShare Advisors LLC’s holdings in DaVita were worth $2,302,000 at the end of the most recent quarter.

Several other institutional investors have also recently added to or reduced their stakes in DVA. Berkshire Hathaway Inc acquired a new stake in DaVita in the second quarter worth $6,425,269,000. BlackRock Inc. bought a new stake in DaVita during the 2nd quarter valued at $547,520,000. Bank of America Corp DE acquired a new position in DaVita during the second quarter worth $145,057,000. Bank of New York Mellon Corp purchased a new stake in shares of DaVita in the second quarter worth approximately $101,127,000. Finally, Deutsche Bank AG bought a new position in shares of DaVita during the second quarter valued at about $46,356,000. 90.12% of the stock is owned by institutional investors and hedge funds.

DaVita Trading Down 1.8%

Shares of NYSE DVA traded down $3.55 during mid-day trading on Friday, hitting $191.27. The company had a trading volume of 603,670 shares, compared to its average volume of 796,165. DaVita Inc. has a 1 year low of $101.00 and a 1 year high of $247.49. The company has a market capitalization of $12.03 billion, a price-to-earnings ratio of 14.08, a P/E/G ratio of 0.47 and a beta of 0.87. The stock’s 50-day moving average price is $182.52 and its 200-day moving average price is $178.61.

DaVita (NYSE:DVA) last posted its earnings results on Thursday, October 29th. The company reported $3.82 earnings per share for the quarter, beating analysts’ consensus estimates of $3.57 by $0.25. DaVita had a negative return on equity of 225.93% and a net margin of 6.49%. The business had revenue of $3.58 billion during the quarter, compared to analyst estimates of $3.52 billion. During the same quarter in the previous year, the firm earned $2.51 EPS. The company’s quarterly revenue was up 4.6% compared to the same quarter last year. As a group, equities research analysts forecast that DaVita Inc. will post 14.66 earnings per share for the current year.

Analyst Ratings Changes

Several research firms recently weighed in on DVA. Deutsche Bank Aktiengesellschaft restated a “buy” rating and set a $265.00 price target on shares of DaVita in a report on Wednesday, August 5th. Barclays dropped their target price on shares of DaVita from $224.00 to $216.00 and set an “equal weight” rating on the stock in a research report on Monday, November 2nd. UBS Group increased their price target on DaVita from $270.00 to $287.00 and gave the company a “buy” rating in a research report on Monday. Weiss Ratings upgraded DaVita from a “hold (c+)” rating to a “buy (b-)” rating in a report on Friday, October 9th. Finally, Raymond James Financial set a $220.00 price objective on DaVita in a research report on Friday, August 7th. Four analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $235.86.

DaVita Company Profile

DaVita Inc (NYSE: DVA) is a health care services company focused on kidney care. Through its DaVita Kidney Care business, the company provides outpatient dialysis treatments for people with chronic kidney failure, including in-center hemodialysis, home dialysis and related clinical support services.

DaVita also offers integrated kidney care programs intended to support patients across the stages of chronic kidney disease. Its services may include care coordination, disease management, education, transplant support and other services designed to improve clinical outcomes and help manage the needs of patients with complex kidney conditions.

The company operates a network of dialysis centers and related facilities in the United States and serves patients in select international markets.